Skip to main content

Table 2 Univariate prognostic analysis of overall survival and disease-free survival in HCC patients

From: Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma

Variable

Overall survival rate (%)

Disease-free survival rate (%)

 

3 y

5 y

P value

3 y

5 y

P value

Gender

      

   Female (n = 12)

91.3

61.8

0.328

66.7

66.7

0.176

   Male (n = 116)

61.9

51.0

 

43.8

43.8

 

Age (years)

      

   ≤ 50 (n = 65)

62.5

52.2

0.567

42.7

42.7

0.101

   > 50 (n = 63)

67.0

51.9

 

49.4

49.4

 

HBsAg status

      

   Negative (n = 18)

88.5

62.1

0.122

71.8

71.8

0.027

   Positive (n = 110)

60.5

49.7

 

41.9

41.9

 

AFP (μg/l)

      

   ≤ 400 (n = 78)

59.3

47.7

0.219

44.3

44.3

0.555

   > 400 (n = 50)

75.0

59.8

 

50.9

50.9

 

Cirrhosis

      

   No (n = 13)

91.7

80.2

0.053

54.9

54.9

0.184

   Yes (n = 115)

61.3

48.1

 

44.6

44.6

 

Child-Pugh classification

     

   A (n = 116)

65.4

55.0

0.378

48.8

48.8

0.154

   B (n = 12)

58.3

29.2

 

20.8

20.8

 

Tumour size (cm)

      

   ≤ 5 (n = 50)

81.7

77.3

< 0.001

72.1

72.1

< 0.001

   > 5 (n = 78)

52.6

36.3

 

29.2

29.2

 

Multiple tumours

      

   No (n = 91)

70.0

60.4

0.002

56.5

56.5

< 0.001

   Yes (n = 37)

49.3

30.2

 

19.8

19.8

 

Tumour capsule

      

   Complete (n = 32)

71.2

71.2

0.165

61.1

61.1

0.096

   No/incomplete (n = 96)

62.5

46.4

 

41.0

41.0

 

Vascular invasion

      

   No (n = 98)

71.7

65.3

< 0.001

54.2

54.2

< 0.001

   Yes (n = 30)

40.8

11.6

 

19.4

19.4

 

TNM stage

      

   I (n = 67)

79.3

72.1

< 0.001

64.7

64.7

< 0.001

   II (n = 30)

54.9

38.4

 

30.8

30.8

 

   III (n = 31)

42.0

22.5

 

20.7

20.7

 

Edmondson-Steiner grade

     

   I/II (n = 69)

75.9

63.0

0.004

56.7

56.7

0.003

   III/IV (n = 59)

50.6

38.4

 

33.4

33.4

 

MACC1 expression level

     

   Low (n = 71)

73.5

61.9

0.003

54.5

54.5

0.008

   High (n = 57)

51.8

37.6

 

33.5

33.5

 
  1. MACC1, metastasis-associated in colon cancer-1; HCC, hepatocellular carcinoma; AFP, α-fetoprotein; HBsAg, hepatitis B surface antigen.